Why the study?
Are IL-8 levels elevated in the synovial fluid of patients with rheumatoid arthritis and do they correlate with markers of disease severity?
Are IL-8 levels elevated in the synovial fluid of patients with rheumatoid arthritis and do they correlate with markers of disease severity?
Elevated IL-8 levels in the synovial fluid of RA patients correlate with cellular influx and CRP, suggesting a pathogenic role for IL-8 in rheumatoid arthritis joint destruction.
This is the authors' abstract. We don't add key points for this paper.
The synovial fluid in affected joints of rheumatoid arthritis (RA) patients contains many cells, in numbers strongly correlated with the severity of disease. As the disease worsens and the cell count increases, the polymorphonuclear leucocyte becomes the predominant cell type. Although the inflammatory cytokines interleukin 1 (IL-1) and tumour necrosis factor (TNF) have no direct neutrophil-attractant activity, they are both potent inducers of interleukin 8 (IL-8) in a variety of cell types. Chemotactic attraction of neutrophils is a major activity of IL-8. Examination of a number of synovial fluids showed that significant levels of IL-8 are present in a high proportion of RA cases (10 out of 17), at concentrations directly related to the number of cells in the joint, and to circulating C-reactive protein (CRP) levels. The cytokine is present only at background levels in other diseases accompanied by arthritic manifestations, including systemic lupus erythematosus (SLE) and induced arthritis. The progressive joint destruction seen in all cases where high IL-8 levels were measured, coupled with the neutrophil-rich cell count and the strong correlation between concentration of IL-8 and both serum CRP and cellular influx into the joint, is strongly suggestive of a pathogenic role for IL-8 in RA.
Answers are grounded in this paper and cite their sources.
IL-8 elevation in RA synovial fluid associates with inflammation; hypothesis-generating for its pathogenic role, needs prospective validation.
No takes yet. Share an insight, caveat, or question.
Peichl et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: